Imanis Life Sciences
PrivateLast Round
Series A
Aug 25, 2021
Total Funding Raised
$8.42M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Imanis Life Sciences operates in Healthcare & Life Sciences and is based in Rochester, Minnesota. Its latest recorded funding round was a Series A round in August 2021.
Imanis Life Sciences is a biotechnology company that provides contract research services and products to accelerate the development of novel therapeutics like oncolytic virus therapies, gene therapies, and vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imanis Life Sciences Comparables
Compare Imanis Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noble Life Sciences | 80% | |
| Ephoran Multi Imaging Solutions | 78% | |
| Oncodesign Services | 77% |
For institutional investors. Book with your work email.
Imanis Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 25, 2021 | ||||
| Grant | Sep 1, 2019 | ||||
| Series A | May 15, 2019 | ||||
| Grant | Aug 1, 2018 | ||||
| Early Funding | Mar 20, 2017 | ||||
Accelerator | Aug 19, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Imanis Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Rochester Area Economic Development, Inc. | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 65% MoM, reaching 6K.
- Jul 25, 2026
Monthly visitors increased 60% MoM.
For institutional investors. Book with your work email.
Imanis Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Imanis Life Sciences's valuation, stock price, and market status.
Is Imanis Life Sciences a public or private company?
Imanis Life Sciences is a private company.
What is the current stock price of Imanis Life Sciences?
Imanis Life Sciences is a private company, so its shares have no public market price. Caplight tracks Imanis Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Imanis Life Sciences worth (valuation)?
Valuation information for Imanis Life Sciences is not publicly available.
Can I buy Imanis Life Sciences stock?
Imanis Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Imanis Life Sciences's last funding round?
Imanis Life Sciences's most recent funding round was Series A on August 25, 2021.
Who are the main investors in Imanis Life Sciences?
Key investors in Imanis Life Sciences include National Cancer Institute, Rochester Area Economic Development, Inc..
Will Imanis Life Sciences IPO soon?
No public IPO plans have been announced for Imanis Life Sciences.
How can I track Imanis Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Imanis Life Sciences's shares on secondary markets.